Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Idera Pharmaceuticals, Inc.

http://www.iderapharma.com

Latest From Idera Pharmaceuticals, Inc.

Russia-Ukraine War Likely To Claim Sputnik V Partners As Casualty

In light of the Russia-Ukraine conflict, Scrip looks at data to gauge if manufacturing partners for COVID-19 vaccine Sputnik V or Light, in India, China and Korea could be left holding unsold inventory earmarked for exports

Commercial Coronavirus COVID-19

Neuraxpharm Expands In Switzerland With New Local Head

Neuraxpharm has appointed Jörg Gärtner to lead its business in Switzerland, as the CNS specialist prepares to roll out its medical cannabis portfolio in the region.

Executive Changes Strategy

Eargo To Pay $34M+ To Resolve False-Claims Allegations

The company, which denies the allegations, allegedly sold hearing aids to federal employees and billed  a government insurance plan without the required hearing assessment.

Legal Issues Policy

CDR-Life Raises $76m To Develop Next-Generation T-Cell Engagers

The Swiss biotech has raised an impressive series A round which will go towards the development of T-cell engagers based on its unique technology, with an eye to reducing off-tumor activity.

Financing ImmunoOncology
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Biotechnology
    • Antisense, Oligonucleotides
    • Large Molecule
  • Other Names / Subsidiaries
    • Hybridon Inc.
UsernamePublicRestriction

Register